FDA Accepts Galderma's BLA Resubmission for Its Liquid Toxin
The FDA has accepted Galderma's resubmitted BLA for its ready-to-use liquid botulinum toxin, restarting a review the agency previously declined to open.
Topic
Biologics License Application
Topic